Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

May 14, 2024

BUY
$0.21 - $0.39 $26,740 - $49,661
127,338 Added 63.19%
328,849 $69,000
Q2 2023

Aug 14, 2023

BUY
$0.21 - $0.39 $26,740 - $49,661
127,338 Added 63.19%
328,849 $69,000
Q1 2023

May 14, 2024

BUY
$0.22 - $0.62 $41,787 - $117,764
189,943 Added 1641.97%
201,511 $56,000
Q1 2023

May 11, 2023

BUY
$0.22 - $0.62 $41,787 - $117,764
189,943 Added 1641.97%
201,511 $56,000
Q4 2022

May 14, 2024

SELL
$0.38 - $1.91 $1,830 - $9,200
-4,817 Reduced 29.4%
11,568 $4,000
Q4 2022

Feb 13, 2023

SELL
$0.38 - $1.91 $1,830 - $9,200
-4,817 Reduced 29.4%
11,568 $4,000
Q3 2022

May 14, 2024

BUY
$1.46 - $2.38 $5,134 - $8,370
3,517 Added 27.33%
16,385 $26,000
Q3 2022

Nov 10, 2022

BUY
$1.46 - $2.38 $5,134 - $8,370
3,517 Added 27.33%
16,385 $26,000
Q2 2022

May 14, 2024

BUY
$1.98 - $5.66 $25,478 - $72,832
12,868 New
12,868 $26,000
Q2 2022

Aug 15, 2022

SELL
$1.98 - $5.66 $117,655 - $336,328
-59,422 Reduced 82.2%
12,868 $26,000
Q1 2022

May 16, 2022

BUY
$4.52 - $12.9 $179,995 - $513,703
39,822 Added 122.65%
72,290 $387,000
Q4 2021

Feb 14, 2022

BUY
$9.01 - $14.1 $292,536 - $457,798
32,468 New
32,468 $405,000

Others Institutions Holding SNCE

About Science 37 Holdings, Inc.


  • Ticker SNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 116,348,000
  • Description
  • Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evid...
More about SNCE
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.